Semaglutide is the FDA-Approved active ingredient used in Wegovy® that has helped thousands of people lose and maintain weight loss in combination with diet and exercise.

For weight management, Semaglutide affects the appetite and promotes a feeling of fullness, leading to reduced calorie intake and weight loss. It is available under different brand names, such as Ozempic® (for type 2 diabetes treatment) and Wegovy® (for weight management) and can be administered through subcutaneous injections.